-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CHS-114 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CHS-114 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CHS-114 in Solid Tumor Drug Details: CHS-114 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CHS-114 in Head And Neck Squamous Cell Carcinoma (HNSC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CHS-114 in Head And Neck Squamous Cell Carcinoma (HNSC) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CHS-114 in Head And Neck Squamous...
-
Product Insights
CH Sabanas
CH Sabanas is a Hydro project located in Antioquia, Colombia. The project is owned and being developed by W.E. Energia Limpia SAS. The project is at the permitting stage. Empower your strategies with our CH Sabanas report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CH-0106 in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CH-0106 in Type 2 Diabetes report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CH-0106 in Type 2 Diabetes Drug Details: CH-0106 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CH-0402 in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CH-0402 in Type 2 Diabetes report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CH-0402 in Type 2 Diabetes Drug Details: CH-0402 is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ChapAte in Hemophilia A (Factor VIII Deficiency)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ChapAte in Hemophilia A (Factor VIII Deficiency) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ChapAte in Hemophilia A (Factor VIII Deficiency) Drug Details:...
-
Analyst Opinions
NewNew Prescription – Generative AI Meets Healthcare (Vol. 2)
Generative Artificial Intelligence (AI) in Healthcare Report Overview GenAI is generating considerable buzz within the healthcare sector, from news updates to deal negotiations and company filings primarily to drive down costs and optimize administrative workflows, promising better healthcare. From accelerating R&D to easing administrative tasks and creating personalized patient experiences, genAI innovations have now proliferated across all the major healthcare application areas. The ’Generative Artificial Intelligence (AI) in Healthcare’ research report is a compendium of the latest real-world innovations in...
-
Sector Analysis
NewMalaysia Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to 2028
Malaysia Construction Market Overview The Malaysia construction market size was $30.1 billion in 2023. The market will achieve an AAGR of more than 5% during 2025-2028, driven by investments in leisure and hospitality infrastructure, manufacturing facilities, roads, and renewable energy. Malaysia Construction Market Outlook, 2023-2028 ($ Billion) Buy the Full Report to Know More about the Malaysia Construction Market Forecast Download a Free Report Sample The Malaysia construction market research report gives a comprehensive understanding of project types and construction...
-
Sector Analysis
Thailand Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to 2028
Thailand Construction Market Report Overview The Thailand construction market size was $25.3 billion in 2023. The market will achieve an AAGR of more than 4% during 2025-2028. The government’s focus on the development of tourism infrastructure, energy generation and housing projects will fuel the market growth during the forecast period. Thailand Construction Market Outlook, 2023-2028 ($ Billion) Buy the Full Report to Know More about the Thailand Construction Market Forecast Download a Free Report Sample The Thailand construction market research...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CH-0601 in Type 1 Diabetes (Juvenile Diabetes)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CH-0601 in Type 1 Diabetes (Juvenile Diabetes) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CH-0601 in Type 1 Diabetes (Juvenile Diabetes) Drug Details:...